JCA Navigator
Discover how our AI-powered solution can help you succeed in the new era of HTA.
The Joint Clinical Assessment (JCA) aims to harmonise clinical evaluations across the EU, reducing duplication of effort for pharmaceutical companies and national HTA bodies. Although it presents new challenges, adopting the right tools can also create opportunities for greater consistency and efficiency in evidence generation across EU markets.
Book a demo to see JCA Navigator in action.
Use AI to predict PICO scenarios using HTA data.
Automate data synthesis from diverse sources.
Compare competitor outcomes for strategic planning.
Consolidates data for unified team views.
Use AI to automate tasks, freeing resources for strategy.
Specific to indications with longitudinal analyses to identify optimal PICO scenarios for major markets and HTAs.
Helping to inform integrated evidence generation planning for assets entering Phase 3, as well as EU HTA and reimbursement strategies.
Automated capture of nuanced PICO details from diverse sources, including published literature, HTAs, clinical trials, and guidelines.
Benchmarking outcomes (efficacy, safety, PROs) against competitors to identify relative clinical benefits and data gaps.
Unlock your superpowers and be the hero your company needs.
Copyright All Rights Reserved
Access Infinity 2025
Get in touch
contact@accessinfinity.com
Uncommon Holborn
81-87 High Holborn,
London
WC1V 6DF
Products